European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery

Denis Querleu, François Planchamp, Luis Chiva, Christina Fotopoulou, Desmond Barton, David Cibula, Giovanni Aletti, Silvestro Carinelli, Carien Creutzberg, Ben Davidson, Philip Harter, Lene Lundvall, Christian Marth, Philippe Morice, Arash Rafii Tabrizi, Isabelle Ray-Coquard, Andrea Rockall, Cristiana Sessa, Ate Van Der Zee, Ignace Vergote & 1 others Andreas Du Bois

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objectives The surgical management of advanced ovarian cancer involves complex surgery. Implementation of a quality management program has a major impact on survival. The goal of this work was to develop a list of quality indicators (QIs) for advanced ovarian cancer surgery that can be used to audit and improve the clinical practice. This task has been carried out under the auspices of the European Society of Gynaecologic Oncology (ESGO). Methods Quality indicators were based on scientific evidence and/or expert consensus. A 4-step evaluation process included a systematic literature search for the identification of potential QIs and the documentation of scientific evidence, physical meetings of an ad hoc multidisciplinarity International Development Group, an internal validation of the targets and scoring system, and an external review process involving physicians and patients. Results Ten structural, process, or outcome indicators were selected. Quality indicators 1 to 3 are related to achievement of complete cytoreduction, caseload in the center, training, and experience of the surgeon. Quality indicators 4 to 6 are related to the overall management, including active participation to clinical research, decision-making process within a structured multidisciplinary team, and preoperative workup. Quality indicator 7 addresses the high value of adequate perioperative management. Quality indicators 8 to 10 highlight the need of recording pertinent information relevant to improvement of quality. An ESGO-approved template for the operative report has been designed. Quality indicators were described using a structured format specifying what the indicator is measuring, measurability specifications, and targets. Each QI was associated with a score, and an assessment form was built. Conclusions The ESGO quality criteria can be used for self-assessment, for institutional or governmental quality assurance programs, and for the certification of centers. Quality indicators and corresponding targets give practitioners and health administrators a quantitative basis for improving care and organizational processes in the surgical management of advanced ovarian cancer.

Original languageEnglish
Pages (from-to)1354-1363
Number of pages10
JournalInternational Journal of Gynecological Cancer
Volume26
Issue number7
DOIs
Publication statusPublished - 1 Sep 2016

Fingerprint

Ovarian Neoplasms
Clinical Audit
Certification
Quality Improvement
Administrative Personnel
Documentation
Consensus
Physicians
Survival
Health
Research
Clinical Decision-Making
Surgeons
Self-Assessment

Keywords

  • Cytoreduction
  • Ovarian cancer
  • Quality assurance

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Querleu, D., Planchamp, F., Chiva, L., Fotopoulou, C., Barton, D., Cibula, D., ... Du Bois, A. (2016). European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery. International Journal of Gynecological Cancer, 26(7), 1354-1363. https://doi.org/10.1097/IGC.0000000000000767

European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery. / Querleu, Denis; Planchamp, François; Chiva, Luis; Fotopoulou, Christina; Barton, Desmond; Cibula, David; Aletti, Giovanni; Carinelli, Silvestro; Creutzberg, Carien; Davidson, Ben; Harter, Philip; Lundvall, Lene; Marth, Christian; Morice, Philippe; Tabrizi, Arash Rafii; Ray-Coquard, Isabelle; Rockall, Andrea; Sessa, Cristiana; Van Der Zee, Ate; Vergote, Ignace; Du Bois, Andreas.

In: International Journal of Gynecological Cancer, Vol. 26, No. 7, 01.09.2016, p. 1354-1363.

Research output: Contribution to journalArticle

Querleu, D, Planchamp, F, Chiva, L, Fotopoulou, C, Barton, D, Cibula, D, Aletti, G, Carinelli, S, Creutzberg, C, Davidson, B, Harter, P, Lundvall, L, Marth, C, Morice, P, Tabrizi, AR, Ray-Coquard, I, Rockall, A, Sessa, C, Van Der Zee, A, Vergote, I & Du Bois, A 2016, 'European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery', International Journal of Gynecological Cancer, vol. 26, no. 7, pp. 1354-1363. https://doi.org/10.1097/IGC.0000000000000767
Querleu, Denis ; Planchamp, François ; Chiva, Luis ; Fotopoulou, Christina ; Barton, Desmond ; Cibula, David ; Aletti, Giovanni ; Carinelli, Silvestro ; Creutzberg, Carien ; Davidson, Ben ; Harter, Philip ; Lundvall, Lene ; Marth, Christian ; Morice, Philippe ; Tabrizi, Arash Rafii ; Ray-Coquard, Isabelle ; Rockall, Andrea ; Sessa, Cristiana ; Van Der Zee, Ate ; Vergote, Ignace ; Du Bois, Andreas. / European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery. In: International Journal of Gynecological Cancer. 2016 ; Vol. 26, No. 7. pp. 1354-1363.
@article{6927003ed2f14f2e8af2ecdacac03cde,
title = "European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery",
abstract = "Objectives The surgical management of advanced ovarian cancer involves complex surgery. Implementation of a quality management program has a major impact on survival. The goal of this work was to develop a list of quality indicators (QIs) for advanced ovarian cancer surgery that can be used to audit and improve the clinical practice. This task has been carried out under the auspices of the European Society of Gynaecologic Oncology (ESGO). Methods Quality indicators were based on scientific evidence and/or expert consensus. A 4-step evaluation process included a systematic literature search for the identification of potential QIs and the documentation of scientific evidence, physical meetings of an ad hoc multidisciplinarity International Development Group, an internal validation of the targets and scoring system, and an external review process involving physicians and patients. Results Ten structural, process, or outcome indicators were selected. Quality indicators 1 to 3 are related to achievement of complete cytoreduction, caseload in the center, training, and experience of the surgeon. Quality indicators 4 to 6 are related to the overall management, including active participation to clinical research, decision-making process within a structured multidisciplinary team, and preoperative workup. Quality indicator 7 addresses the high value of adequate perioperative management. Quality indicators 8 to 10 highlight the need of recording pertinent information relevant to improvement of quality. An ESGO-approved template for the operative report has been designed. Quality indicators were described using a structured format specifying what the indicator is measuring, measurability specifications, and targets. Each QI was associated with a score, and an assessment form was built. Conclusions The ESGO quality criteria can be used for self-assessment, for institutional or governmental quality assurance programs, and for the certification of centers. Quality indicators and corresponding targets give practitioners and health administrators a quantitative basis for improving care and organizational processes in the surgical management of advanced ovarian cancer.",
keywords = "Cytoreduction, Ovarian cancer, Quality assurance",
author = "Denis Querleu and Fran{\cc}ois Planchamp and Luis Chiva and Christina Fotopoulou and Desmond Barton and David Cibula and Giovanni Aletti and Silvestro Carinelli and Carien Creutzberg and Ben Davidson and Philip Harter and Lene Lundvall and Christian Marth and Philippe Morice and Tabrizi, {Arash Rafii} and Isabelle Ray-Coquard and Andrea Rockall and Cristiana Sessa and {Van Der Zee}, Ate and Ignace Vergote and {Du Bois}, Andreas",
year = "2016",
month = "9",
day = "1",
doi = "10.1097/IGC.0000000000000767",
language = "English",
volume = "26",
pages = "1354--1363",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery

AU - Querleu, Denis

AU - Planchamp, François

AU - Chiva, Luis

AU - Fotopoulou, Christina

AU - Barton, Desmond

AU - Cibula, David

AU - Aletti, Giovanni

AU - Carinelli, Silvestro

AU - Creutzberg, Carien

AU - Davidson, Ben

AU - Harter, Philip

AU - Lundvall, Lene

AU - Marth, Christian

AU - Morice, Philippe

AU - Tabrizi, Arash Rafii

AU - Ray-Coquard, Isabelle

AU - Rockall, Andrea

AU - Sessa, Cristiana

AU - Van Der Zee, Ate

AU - Vergote, Ignace

AU - Du Bois, Andreas

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Objectives The surgical management of advanced ovarian cancer involves complex surgery. Implementation of a quality management program has a major impact on survival. The goal of this work was to develop a list of quality indicators (QIs) for advanced ovarian cancer surgery that can be used to audit and improve the clinical practice. This task has been carried out under the auspices of the European Society of Gynaecologic Oncology (ESGO). Methods Quality indicators were based on scientific evidence and/or expert consensus. A 4-step evaluation process included a systematic literature search for the identification of potential QIs and the documentation of scientific evidence, physical meetings of an ad hoc multidisciplinarity International Development Group, an internal validation of the targets and scoring system, and an external review process involving physicians and patients. Results Ten structural, process, or outcome indicators were selected. Quality indicators 1 to 3 are related to achievement of complete cytoreduction, caseload in the center, training, and experience of the surgeon. Quality indicators 4 to 6 are related to the overall management, including active participation to clinical research, decision-making process within a structured multidisciplinary team, and preoperative workup. Quality indicator 7 addresses the high value of adequate perioperative management. Quality indicators 8 to 10 highlight the need of recording pertinent information relevant to improvement of quality. An ESGO-approved template for the operative report has been designed. Quality indicators were described using a structured format specifying what the indicator is measuring, measurability specifications, and targets. Each QI was associated with a score, and an assessment form was built. Conclusions The ESGO quality criteria can be used for self-assessment, for institutional or governmental quality assurance programs, and for the certification of centers. Quality indicators and corresponding targets give practitioners and health administrators a quantitative basis for improving care and organizational processes in the surgical management of advanced ovarian cancer.

AB - Objectives The surgical management of advanced ovarian cancer involves complex surgery. Implementation of a quality management program has a major impact on survival. The goal of this work was to develop a list of quality indicators (QIs) for advanced ovarian cancer surgery that can be used to audit and improve the clinical practice. This task has been carried out under the auspices of the European Society of Gynaecologic Oncology (ESGO). Methods Quality indicators were based on scientific evidence and/or expert consensus. A 4-step evaluation process included a systematic literature search for the identification of potential QIs and the documentation of scientific evidence, physical meetings of an ad hoc multidisciplinarity International Development Group, an internal validation of the targets and scoring system, and an external review process involving physicians and patients. Results Ten structural, process, or outcome indicators were selected. Quality indicators 1 to 3 are related to achievement of complete cytoreduction, caseload in the center, training, and experience of the surgeon. Quality indicators 4 to 6 are related to the overall management, including active participation to clinical research, decision-making process within a structured multidisciplinary team, and preoperative workup. Quality indicator 7 addresses the high value of adequate perioperative management. Quality indicators 8 to 10 highlight the need of recording pertinent information relevant to improvement of quality. An ESGO-approved template for the operative report has been designed. Quality indicators were described using a structured format specifying what the indicator is measuring, measurability specifications, and targets. Each QI was associated with a score, and an assessment form was built. Conclusions The ESGO quality criteria can be used for self-assessment, for institutional or governmental quality assurance programs, and for the certification of centers. Quality indicators and corresponding targets give practitioners and health administrators a quantitative basis for improving care and organizational processes in the surgical management of advanced ovarian cancer.

KW - Cytoreduction

KW - Ovarian cancer

KW - Quality assurance

UR - http://www.scopus.com/inward/record.url?scp=84985918226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985918226&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000767

DO - 10.1097/IGC.0000000000000767

M3 - Article

VL - 26

SP - 1354

EP - 1363

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 7

ER -